AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 14th, 2010 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Investor Rights Agreement (this “Agreement”) is entered into as of February 27, 2007 by and among TransOral Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the entities and individuals listed on Exhibit A attached hereto (the “Prior Investors”), and the entities and individuals listed on Exhibit B attached hereto (the “New Investors” and together with the Prior Investors, the “Investors”).
TRANSCEPT PHARMACEUTICALS, INC. TERMINATION AGREEMENTTermination Agreement • May 14th, 2010 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This Termination Agreement (this “Agreement”) is entered into as of January 26, 2009 by and between Transcept Pharmaceuticals, Inc. (the “Company”) and the undersigned holders (the “Stockholders”) of shares of Preferred Stock of the Company.
